Physician profile
Alan D Brown
NPI 1982601209
$3,777.17
in general payments reported to CMS, 2019-2025
19 companies · $582 in 2025
The $582 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $611 · 2020: $427 · 2021: $332 · 2022: $1,083 · 2023: $333 · 2024: $409 · 2025: $582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $530.98 | 2019-2024 | Total30, Precision 1, Precision 7 |
| Glaukos Corporation | $520.82 | 2020-2025 | |
| Sun Pharmaceutical Industries INC. | $480.11 | 2020-2025 | |
| Abbvie INC. | $399.51 | 2022-2024 | Lumigan, Vuity, Alphagan P |
| Bausch & Lomb Americas INC. | $228.62 | 2023-2025 | Miebo, Xipere, Vyzulta |
| Allergan, INC. | $228.55 | 2019-2022 | |
| Johnson & Johnson Vision Care, INC. | $227.85 | 2022-2024 | Acuvue |
| Johnson & Johnson Surgical Vision, INC. | $224.68 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $180.93 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $166.04 | 2019-2021 | |
| Sight Sciences, INC. | $147.20 | 2025 | Tearcare System |
| Oyster Point Pharma, INC. | $125.40 | 2022 | |
| Carl Zeiss Meditec, INC. | $118.33 | 2019 | |
| Genentech USA, INC. | $89.38 | 2023-2024 | Vabysmo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $34.39 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $19.84 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.31 | 2021 | |
| Alimera Sciences, INC. | $18.88 | 2022 | |
| Coopervision INC. | $16.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.